Zobrazeno 1 - 6
of 6
pro vyhledávání: '"S. Abdul Wahid Fadilah"'
Autor:
Soon Keng Cheong, John E Anderson, S. Abdul Wahid Fadilah, Oteh Maskon, Chiang Soo Tan, Chee-Yin Wong, Hamat Hamdi Che Hassan, C.K. Choor, S. Chin
Publikováno v:
Stem Cell Investig
Background Ischemic cardiomyopathy (ICM) is a leading cause of cardiovascular mortality worldwide. It is defined as abnormal enlargement of the left ventricular (LV) cavity with poor LV function due to coronary artery disease. Currently available est
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2f7026b2598259406bba3b1d9a332b
https://doi.org/10.21037/sci-2020-026
https://doi.org/10.21037/sci-2020-026
Autor:
Ravindran Ankathil, Teh A, Abdul Aziz Baba, Ai Sim Goh, H Rosline, S. Abdul Wahid Fadilah, Anthony Au
Publikováno v:
Biomedicine & Pharmacotherapy. 68:343-349
The introduction and success of imatinib mesylate (IM) has become a paradigm shift in chronic myeloid leukemia (CML) treatment. However, the high efficacy of IM has been hampered by the issue of clinical resistance that might due to pharmacogenetic v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c43547c1da1a3269521fbdc8a9593a9b
https://doi.org/10.1016/j.biopha.2014.01.009
https://doi.org/10.1016/j.biopha.2014.01.009
Autor:
Kong-Chiew-Tong Norella, S-Abdul Wahid Fadilah, Mohd-Said Shahril, Raja-Sabudin Azma, Chooi-Fun Leong, Soon Keng Cheong
Publikováno v:
APLAR Journal of Rheumatology. 9:286-289
Interferon-alpha (IFN-α) therapy has been associated with de novo development of systemic lupus erythematosus (SLE), and discontinuation of IFN-α resulted in disease resolution in most patients. Recurrence of SLE in the absence of concomitant IFN-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d69ea2cf9917377114b6b71ee1202d9
https://doi.org/10.1111/j.1479-8077.2006.00216.x
https://doi.org/10.1111/j.1479-8077.2006.00216.x
Autor:
Abdul Aziz Baba, Ravindran Ankathil, Marjanu Hikmah Elias, Goh Ai Sim, Menon Padmini, S. Abdul Wahid Fadilah, H Rosline, Husin Azlan
Publikováno v:
Leukemia research. 38(4)
Discovery of imatinib mesylate (IM) as the targeted BCR-ABL protein tyrosine kinase inhibitor (TKI) has resulted in its use as the frontline therapy for chronic myeloid leukemia (CML) across the world. Although high response rates are observed in CML
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc9f353121955e75232fcfe5084a5fb3
https://pubmed.ncbi.nlm.nih.gov/24456693
https://pubmed.ncbi.nlm.nih.gov/24456693
Publikováno v:
The Malaysian journal of pathology. 28(1)
Intense myelofibrosis is rarely associated with de novo acute myeloid leukaemia (AML) except in acute megakaryoblastic leukaemia (AML-M7) where there is diffuse marrow fibrosis as a consequence of proliferation of neoplastic myeloid cells. AML associ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3ec336269e7d849bd770d39ac5fcfbb4
https://pubmed.ncbi.nlm.nih.gov/17694960
https://pubmed.ncbi.nlm.nih.gov/17694960
Publikováno v:
British Journal of Haematology; Mar2002, Vol. 116 Issue 4, p731-731, 1p, 1 Black and White Photograph